MoxDuo IR morphine/oxycodone regulatory update

FDA's Anesthetic and Analgesic Drug Products Advisory Committee voted 14-0 against approval of QRxPharma's MoxDuo IR morphine/oxycodone to treat moderate to severe acute pain. The

Read the full 258 word article

How to gain access

Continue reading with a
two-week free trial.